Literature DB >> 24060365

The influence of preoperative weight loss on the postoperative course after esophageal cancer resection.

Maartje K van der Schaaf1, Hugo W Tilanus2, Jan J B van Lanschot2, Asif M Johar3, Pernilla Lagergren3, Jesper Lagergren4, Bas P L Wijnhoven2.   

Abstract

OBJECTIVE: Preoperative weight loss might increase the risk of postoperative morbidity and mortality after esophagectomy for cancer. We hypothesized that patients with esophageal cancer with >10% weight loss during the 3 months before their diagnosis would be at an increased risk of postoperative complications, have a longer length of stay, and have worse overall survival.
METHODS: In the present hospital-based cohort study, all patients who had undergone surgery for esophageal cancer in 1990 to 2010 at the Erasmus University Medical Center Rotterdam were included. Weight loss was defined as "no, or limited" (≤10%) or "severe" (>10%). Logistic regression analysis was used to estimate the relative risk of complications, expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Hazard ratios were calculated to assess the length of hospital stay and survival. The risk estimates were adjusted for potential confounding factors.
RESULTS: Of 922 included patients, 155 (17%) had experienced severe weight loss. These patients had no increased risk of early surgical, early nonsurgical, or late surgical complications (OR, 0.83 and 95% CI, 0.54-1.24; OR, 0.90 and 95% CI, 0.63-1.30; OR, 1.14 and 95% CI, 0.79-1.66, respectively) and had no increased length of stay (hazard ratio, 1.09; 95% CI, 0.89-1.35). Preoperative weight loss was followed by increased 5-year mortality (hazard ratio, 1.34; 95% CI, 1.02-1.74).
CONCLUSIONS: A >10% preoperative weight loss was followed by decreased 5-year survival after esophageal cancer surgery but no increased risk of postoperative complications.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  7; BMI; CI; HR; OR; body mass index; confidence interval; hazard ratio; odds ratio

Mesh:

Year:  2013        PMID: 24060365     DOI: 10.1016/j.jtcvs.2013.07.072

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  29 in total

Review 1.  Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms.

Authors:  Cornelia M Ulrich; Caroline Himbert; Andreana N Holowatyj; Stephen D Hursting
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-11       Impact factor: 46.802

Review 2.  Feeding Challenges in Patients with Esophageal and Gastroesophageal Cancers.

Authors:  Daniel Reim; Helmut Friess
Journal:  Gastrointest Tumors       Date:  2016-01-08

3.  Actual Sarcopenia Reflects Poor Prognosis in Patients with Esophageal Cancer.

Authors:  Akihiro Watanabe; Taro Oshikiri; Ryuichiro Sawada; Hitoshi Harada; Naoki Urakawa; Hironobu Goto; Hiroshi Hasegawa; Shingo Kanaji; Kimihiro Yamashita; Takeru Matsuda; Daisuke Makiura; Yoshihiro Kakeji
Journal:  Ann Surg Oncol       Date:  2022-02-15       Impact factor: 5.344

Review 4.  Update on Management of Squamous Cell Esophageal Cancer.

Authors:  John K Waters; Scott I Reznik
Journal:  Curr Oncol Rep       Date:  2022-02-10       Impact factor: 5.075

5.  Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.

Authors:  Tomoki Abe; Taro Oshikiri; Hironobu Goto; Takashi Kato; Manabu Horikawa; Ryuichiro Sawada; Hitoshi Harada; Naoki Urakawa; Hiroshi Hasegawa; Shingo Kanaji; Kimihiro Yamashita; Takeru Matsuda; Yoshihiro Kakeji
Journal:  Ann Surg Oncol       Date:  2021-11-22       Impact factor: 5.344

Review 6.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

7.  Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.

Authors:  S Shen; J L Araujo; N K Altorki; J R Sonett; A Rodriguez; K Sungur-Stasik; C F Spinelli; A I Neugut; J A Abrams
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

Review 8.  Effects of Enteral Immunonutrition in Esophageal Cancer.

Authors:  Kenji Mimatsu; Nobutada Fukino; Yasuo Ogasawara; Yoko Saino; Takatsugu Oida
Journal:  Gastrointest Tumors       Date:  2017-11-23

9.  Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study.

Authors:  Zihui Tan; Hong Yang; Jing Wen; Kongjia Luo; Qianwen Liu; Yihuai Hu; Lanjun Zhang; Mengzhong Liu; Jingping Yun; Jianhua Fu
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

10.  A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma.

Authors:  Gregory Vlacich; Andrew Ballard; Shahed N Badiyan; Matthew Spraker; Lauren Henke; Hyun Kim; A Craig Lockhart; Haeseong Park; Rama Suresh; Yi Huang; Cliff G Robinson; Jeffrey D Bradley; Pamela P Samson
Journal:  Clin Transl Radiat Oncol       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.